GTM & Commercial Strategy

The company needed to decide how to prioritize a multi-product GenAI portfolio for near-term enterprise growth. I evaluated each offering based on buyer urgency, adoption friction, sales motion, and commercial readiness. I recommended a GTM sequence that led with the strongest near-term opportunity and used advisory-led discovery to open enterprise conversations. Within the first six months, the approach supported several pilots and initial customer engagements.

Open GTM strategy memo ↗

After seeing our product demo, the client approached us with a customized clinical AI use case. I translated their requirements into a defined scope, success criteria, fixed-fee pricing, and a path to production. The proposal resulted in a $320K statement of work to customize the two-step application, with additional ongoing revenue from user access and maintenance.

Open pricing and packaging memo ↗